+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Kidney Disease Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product Type (Diagnosis, Treatment); End User (Hospital, Diagnostic Laboratories, Others), and Geography

  • ID: 5178579
  • Report
  • September 2020
  • Region: Global
  • 215 pages
  • The Insight Partners
UP TO OFF
until Jan 15th 2021
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Abbott
  • AbbVie's Inc.
  • Amgen Inc.
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline plc
  • Pfizer Inc.
  • MORE
Diagnosis Segment to Grow at Fast Pace during2020-2027

According to this latest study on“Kidney Disease MarketForecast to 2027 - COVID-19 Impact and Global Analysis - by Product Type and End User,”the market is expected to reach US$ 133,444.71 million by 2027 from US$ 81,128.11millionin 2019; it is estimated to grow ata CAGR of 6.5% from 2020 to 2027. The report provides trends prevailing in the global kidney disease market,and the drivers and hindrances pertaining to the market growth.

Based on product type, the global kidney disease marketis segmented into diagnosis and treatment. The diagnosis segment is estimated to register the highest CAGR in the market during the forecast period.Kidney diseasescan be diagnosed with the help of various tests, such as blood tests, urine tests, and imaging tests. The tests must be performed in case of diabetes, high blood pressure, heart disease, and a family history of kidney failure. Early kidney disease usually doesnot show any symptoms. Testing is the only way to know how well kidneys are working.Increasing number of treatment procedures and product development are likely to propel the market's growth during the forecast period.

High prevalence of chronic diseases leading to kidney diseases and favorable reimbursement policy for the kidney disease treatments are the key factors driving the growth of the kidney disease market. Moreover, increase in preference for robotic surgeries for kidney diseases is likely to have positive impact on the market in the coming years. However, undiagnosed cases of kidney disease are restricting the market growth.

Abbott, F. Hoffmann-La Roche Ltd, AbbVie's Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd, GlaxoSmithKline plc, Amgen Inc., Sysmex Corp, Fresenius Medical Care SE & Co. KGaA,and Siemens Healthineers AG are among the leading companies operating in the kidney disease market.

The report segments theglobal kidney disease market as follows:

By Product Type
  • Diagnosis
  • Blood Tests
  • Urine Tests
  • Imaging Tests
  • Others
  • Treatment
  • Drug Class
  • ACE Inhibitors
  • Angiotensin-II Receptor Blockers
  • Diuretics
  • Others
By End-User
  • Hospitals
  • Diagnostic Laboratories
  • Others
By Geography

North America
  • US
  • Canada
  • Mexico
Europe
  • France
  • Germany
  • UK
  • Spain
  • Italy
Asia Pacific (APAC)
  • China
  • India
  • Japan
  • Australia
  • South Korea
Middle East & Africa (MEA)
  • Saudi Arabia
  • UAE
  • South Africa
  • South and Central America (SCAM)
  • Brazil
  • Argentina
Reasons to Buy
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Kidney disease market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global Kidney disease market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abbott
  • AbbVie's Inc.
  • Amgen Inc.
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline plc
  • Pfizer Inc.
  • MORE
1. Introduction
1.1 Scope of the Study
1.2 Report Guidance
1.3 Market Segmentation
1.3.1 Kidney Disease Market - By Product Type
1.3.2 Kidney Disease Market - By End User
1.3.3 Global Kidney Disease Market - By Geography

2. Kidney Disease Market - Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Global Kidney Disease- Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America - PEST Analysis
4.2.2 Europe - PEST Analysis
4.2.3 Asia Pacific - PEST Analysis
4.2.4 Middle East and Africa (MEA) - PEST Analysis
4.2.5 South and Central America (SCAM) - PEST Analysis
4.3 Expert Opinions

5. Kidney Disease Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 High Prevalence of Chronic Diseases Leading to Kidney Diseases
5.1.2 Favorable Reimbursement Policy for Kidney Disease Treatments
5.2 Market Restraints
5.2.1 Undiagnosed Cases of Kidney Disease
5.3 Market Opportunities
5.3.1 Increase in Preference for Robotic Surgeries for Kidney Diseases
5.4 Future Trends
5.4.1 Rise in Preference for Advanced Hemodialysis Therapies
5.5 Impact Analysis

6. Kidney Disease Market - Global Analysis
6.1 Global Kidney Disease Marker Revenue Forecast And Analysis
6.2 Global Kidney Disease Market, By Geography - Forecast And Analysis
6.3 Market Positioning of Key Players

7. Kidney Disease Market Analysis - By Product Type
7.1 Overview
7.2 Kidney Disease Market Revenue Share, by Product Type (2019 and 2027)
7.3 Diagnosis
7.3.1 Overview
7.3.2 Diagnosis: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
7.3.3 Blood Tests
7.3.3.1 Overview
7.3.3.2 Blood Tests: Kidney Disease Market - Revenue and Forecast to 2027(US$ Million)
7.3.4 Urine Tests
7.3.4.1 Overview
7.3.4.2 Urine Tests: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
7.3.5 Imaging Tests
7.3.5.1 Overview
7.3.5.2 Imaging Tests: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
7.3.6 Others
7.3.6.1 Overview
7.3.6.2 Others: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
7.4 Treatment
7.4.1 Overview
7.4.2 Treatment: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
7.4.3 Drug Class
7.4.3.1 Overview
7.4.3.2 Drug Class: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
7.4.3.2.1 ACE Inhibitors
7.4.3.2.1.1 Overview
7.4.3.2.1.2 ACE Inhibitors: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
7.4.3.2.2 Angiotensin-II Receptor Blockers
7.4.3.2.2.1 Overview
7.4.3.2.2.2 Angiotensin-II Receptor Blockers: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
7.4.3.2.3 Diuretics
7.4.3.2.3.1 Overview
7.4.3.2.3.2 Diuretics: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
7.4.3.2.4 Others
7.4.3.2.4.1 Overview
7.4.3.2.4.2 Others: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
7.4.4 Dialysis
7.4.4.1 Overview
7.4.4.2 Dialysis: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
7.4.5 Others
7.4.5.1 Overview
7.4.5.2 Others: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)

8. Kidney Disease Market Analysis - By End User
8.1 Overview
8.2 Kidney Disease Market Revenue Share, by End User (2019 and 2027)
8.3 Hospitals
8.3.1 Overview
8.3.2 Hospitals: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
8.4 Diagnostic Laboratories
8.4.1 Overview
8.4.2 Diagnostic Laboratories: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)

9. Kidney Disease Market Analysis and Forecasts To 2027 - Geographical Analysis
9.1 North America: Kidney Disease Market
9.1.1 Overview
9.1.2 North America: Kidney Disease Market - Revenue and Forecast to 2027 (USD Million)
9.1.3 North America: Kidney Disease Market, by Product Type - Revenue and Forecast to 2027 (USD Million)
9.1.3.1 North America: Kidney Disease Market, by Diagnosis - Revenue and Forecast to 2027 (USD Million)
9.1.3.2 North America: Kidney Disease Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
9.1.3.2.1 North America: Kidney Disease Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
9.1.4 North America: Kidney Disease Market, by End User - Revenue and Forecast to 2027 (USD Million)
9.1.5 North America: Kidney Disease Market, by Country, 2019 & 2027 (%)
9.1.6 US: Kidney Disease Market - Revenue and Forecast to 2027 (USD Million)
9.1.6.1 US: Kidney Disease Market - Revenue and Forecast to 2027 (USD Million)
9.1.6.2 US: Kidney Disease Market, by Product Type - Revenue and Forecast to 2027 (USD Million)
9.1.6.2.1 US: Kidney Disease Market, by Diagnosis - Revenue and Forecast to 2027 (USD Million)
9.1.6.2.2 US: Kidney Disease Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
9.1.6.2.2.1 US: Kidney Disease Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
9.1.6.3 US: Kidney Disease Market, by End User - Revenue and Forecast to 2027 (USD Million)
9.1.7 Canada: Kidney Disease Market - Revenue and Forecast to 2027 (USD Million)
9.1.7.1 Canada: Kidney Disease Market - Revenue and Forecast to 2027 (USD Million)
9.1.7.2 Canada: Kidney Disease Market, by Product Type - Revenue and Forecast to 2027 (USD Million)
9.1.7.2.1 Canada: Kidney Disease Market, by Diagnosis - Revenue and Forecast to 2027 (USD Million)
9.1.7.2.2 Canada: Kidney Disease Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
9.1.7.2.2.1 Canada: Kidney Disease Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
9.1.7.3 Canada: Kidney Disease Market, by End User - Revenue and Forecast to 2027 (USD Million)
9.1.8 Mexico: Kidney Disease Market - Revenue and Forecast to 2027 (USD Million)
9.1.8.1 Mexico: Kidney Disease Market - Revenue and Forecast to 2027 (USD Million)
9.1.8.2 Mexico: Kidney Disease Market, by Product Type - Revenue and Forecast to 2027 (USD Million)
9.1.8.2.1 Mexico: Kidney Disease Market, by Diagnosis - Revenue and Forecast to 2027 (USD Million)
9.1.8.2.2 Mexico: Kidney Disease Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
9.1.8.2.2.1 Mexico: Kidney Disease Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
9.1.8.3 Mexico: Kidney Disease Market, by End User - Revenue and Forecast to 2027 (USD Million)
9.2 Europe: Kidney Disease Market
9.2.1 Overview
9.2.2 Europe: Kidney Disease Market, - Revenue and Forecast to 2027 (USD Million)
9.2.3 Europe: Kidney Disease Market, by Product Type - Revenue and Forecast to 2027 (USD Million)
9.2.3.1 Europe: Kidney Disease Market, by Diagnosis - Revenue and Forecast to 2027 (USD Million)
9.2.3.2 Europe: Kidney Disease Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
9.2.3.2.1 Europe: Kidney Disease Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
9.2.4 Europe: Kidney Disease Market, by End User - Revenue and Forecast to 2027 (USD Million)
9.2.5 Europe: Kidney Disease Market, by Country, 2019 & 2027 (%)
9.2.6 Germany: Kidney Disease Market - Revenue and Forecast to 2027 (USD Million)
9.2.6.1 Germany: Kidney Disease Market - Revenue and Forecast to 2027 (USD Million)
9.2.6.2 Germany: Kidney Disease Market, by Product Type - Revenue and Forecast to 2027 (USD Million)
9.2.6.2.1 Germany: Kidney Disease Market, by Diagnosis - Revenue and Forecast to 2027 (USD Million)
9.2.6.2.2 Germany: Kidney Disease Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
9.2.6.2.2.1 Germany: Kidney Disease Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
9.2.6.3 Germany: Kidney Disease Market, by End User - Revenue and Forecast to 2027 (USD Million)
9.2.7 UK: Kidney Disease Market - Revenue and Forecast to 2027 (USD Million)
9.2.7.1 UK: Kidney Disease Market - Revenue and Forecast to 2027 (USD Million)
9.2.7.2 UK: Kidney Disease Market, by Product Type - Revenue and Forecast to 2027 (USD Million)
9.2.7.2.1 UK: Kidney Disease Market, by Diagnosis - Revenue and Forecast to 2027 (USD Million)
9.2.7.2.2 UK: Kidney Disease Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
9.2.7.2.2.1 UK: Kidney Disease Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
9.2.7.3 UK: Kidney Disease Market, by End User - Revenue and Forecast to 2027 (USD Million)
9.2.8 France: Kidney Disease Market - Revenue and Forecast to 2027 (USD Million)
9.2.8.1 France: Kidney Disease Market - Revenue and Forecast to 2027 (USD Million)
9.2.8.2 France: Kidney Disease Market, by Product Type - Revenue and Forecast to 2027 (USD Million)
9.2.8.2.1 France: Kidney Disease Market, by Diagnosis - Revenue and Forecast to 2027 (USD Million)
9.2.8.2.2 France: Kidney Disease Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
9.2.8.2.2.1 France: Kidney Disease Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
9.2.8.3 France: Kidney Disease Market, by End User - Revenue and Forecast to 2027 (USD Million)
9.2.9 Italy: Kidney Disease Market - Revenue and Forecast to 2027 (USD Million)
9.2.9.1 Italy: Kidney Disease Market - Revenue and Forecast to 2027 (USD Million)
9.2.9.2 Italy: Kidney Disease Market, by Product Type - Revenue and Forecast to 2027 (USD Million)
9.2.9.2.1 Italy: Kidney Disease Market, by Diagnosis - Revenue and Forecast to 2027 (USD Million)
9.2.9.2.2 Italy: Kidney Disease Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
9.2.9.2.2.1 Italy: Kidney Disease Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
9.2.9.3 Italy: Kidney Disease Market, by End User - Revenue and Forecast to 2027 (USD Million)
9.2.10 Spain: Kidney Disease Market - Revenue and Forecast to 2027 (USD Million)
9.2.10.1 Spain: Kidney Disease Market - Revenue and Forecast to 2027 (USD Million)
9.2.10.2 Spain: Kidney Disease Market, by Product Type - Revenue and Forecast to 2027 (USD Million)
9.2.10.2.1 Spain: Kidney Disease Market, by Diagnosis - Revenue and Forecast to 2027 (USD Million)
9.2.10.2.2 Spain: Kidney Disease Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
9.2.10.2.2.1 Spain: Kidney Disease Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
9.2.10.3 Spain: Kidney Disease Market, by End User - Revenue and Forecast to 2027 (USD Million)
9.3 Asia Pacific: Kidney Disease Market
9.3.1 Overview
9.3.2 Asia Pacific: Kidney Disease Market, - Revenue and Forecast to 2027 (USD Million)
9.3.2.1 Canada: Kidney Disease Market, by Product Type - Revenue and Forecast to 2027 (USD Million)
9.3.2.1.1 Asia Pacific: Kidney Disease Market, by Diagnosis - Revenue and Forecast to 2027 (USD Million)
9.3.2.1.2 Asia Pacific: Kidney Disease Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
9.3.2.1.2.1 Asia Pacific: Kidney Disease Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
9.3.2.2 Asia Pacific: Kidney Disease Market, by End User - Revenue and Forecast to 2027 (USD Million)
9.3.3 Asia Pacific: Kidney Disease Market, by Country, 2019 & 2027 (%)
9.3.4 Japan: Kidney Disease Market - Revenue and Forecast to 2027 (USD Million)
9.3.4.1 Japan: Kidney Disease Market - Revenue and Forecast to 2027 (USD Million)
9.3.4.2 Japan: Kidney Disease Market, by Product Type - Revenue and Forecast to 2027 (USD Million)
9.3.4.2.1 Japan: Kidney Disease Market, by Diagnosis - Revenue and Forecast to 2027 (USD Million)
9.3.4.2.2 Japan: Kidney Disease Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
9.3.4.2.2.1 Japan: Kidney Disease Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
9.3.4.3 Japan: Kidney Disease Market, by End User - Revenue and Forecast to 2027 (USD Million)
9.3.5 China: Kidney Disease Market - Revenue and Forecast to 2027 (USD Million)
9.3.5.1 China: Kidney Disease Market - Revenue and Forecast to 2027 (USD Million)
9.3.5.2 China: Kidney Disease Market, by Product Type - Revenue and Forecast to 2027 (USD Million)
9.3.5.2.1 China: Kidney Disease Market, by Diagnosis - Revenue and Forecast to 2027 (USD Million)
9.3.5.2.2 China: Kidney Disease Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
9.3.5.2.2.1 China: Kidney Disease Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
9.3.5.3 China: Kidney Disease Market, by End User - Revenue and Forecast to 2027 (USD Million)
9.3.6 India: Kidney Disease Market - Revenue and Forecast to 2027 (USD Million)
9.3.6.1 India: Kidney Disease Market - Revenue and Forecast to 2027 (USD Million)
9.3.6.2 India: Kidney Disease Market, by Product Type - Revenue and Forecast to 2027 (USD Million)
9.3.6.2.1 India: Kidney Disease Market, by Diagnosis - Revenue and Forecast to 2027 (USD Million)
9.3.6.2.2 India: Kidney Disease Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
9.3.6.2.2.1 India: Kidney Disease Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
9.3.6.3 India: Kidney Disease Market, by End User - Revenue and Forecast to 2027 (USD Million)
9.3.7 South Korea: Kidney Disease Market - Revenue and Forecast to 2027 (USD Million)
9.3.7.1 South Korea: Kidney Disease Market - Revenue and Forecast to 2027 (USD Million)
9.3.7.2 South Korea: Kidney Disease Market, by Product Type - Revenue and Forecast to 2027 (USD Million)
9.3.7.2.1 South Korea: Kidney Disease Market, by Diagnosis - Revenue and Forecast to 2027 (USD Million)
9.3.7.2.2 South Korea: Kidney Disease Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
9.3.7.2.2.1 South Korea: Kidney Disease Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
9.3.7.3 South Korea: Kidney Disease Market, by End User - Revenue and Forecast to 2027 (USD Million)
9.3.8 Australia: Kidney Disease Market - Revenue and Forecast to 2027 (USD Million)
9.3.8.1 Australia: Kidney Disease Market - Revenue and Forecast to 2027 (USD Million)
9.3.8.2 Australia: Kidney Disease Market, by Product Type - Revenue and Forecast to 2027 (USD Million)
9.3.8.2.1 Australia: Kidney Disease Market, by Diagnosis - Revenue and Forecast to 2027 (USD Million)
9.3.8.2.2 Australia: Kidney Disease Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
9.3.8.2.2.1 Australia: Kidney Disease Market, by Drug Class- Revenue and Forecast to 2027 (USD Million)
9.3.8.3 Australia: Kidney Disease Market, by End User - Revenue and Forecast to 2027 (USD Million)
9.4 Middle East & Africa: Kidney Disease Market
9.4.1 Overview
9.4.2 Middle East & Africa: Kidney Disease Market - Revenue and Forecast to 2027 (US$ Million)
9.4.3 Middle East and Africa: Kidney Disease Market, by Product Type - Revenue and Forecast to 2027 (USD Million)
9.4.3.1 Middle East and Africa: Kidney Disease Market, by Diagnosis - Revenue and Forecast to 2027 (USD Million)
9.4.3.2 Middle East and Africa: Kidney Disease Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
9.4.3.2.1 Middle East and Africa: Kidney Disease Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
9.4.4 Middle East and Africa: Kidney Disease Market, by End User - Revenue and Forecast to 2027 (USD Million)
9.4.5 Middle East & Africa: Kidney Disease Market, by Country, 2019& 2027 (%)
9.4.6 Saudi Arabia: Kidney Disease Market - Revenue and Forecast to 2027 (USD Million)
9.4.6.1 Saudi Arabia: Kidney Disease Market - Revenue and Forecast to 2027 (USD Million)
9.4.6.2 Saudi Arabia: Kidney Disease Market, by Product Type - Revenue and Forecast to 2027 (USD Million)
9.4.6.2.1 Saudi Arabia: Kidney Disease Market, by Diagnosis - Revenue and Forecast to 2027 (USD Million)
9.4.6.2.2 Saudi Arabia: Kidney Disease Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
9.4.6.2.2.1 Saudi Arabia: Kidney Disease Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
9.4.6.3 Saudi Arabia: Kidney Disease Market, by End User - Revenue and Forecast to 2027 (USD Million)
9.4.7 UAE: Kidney Disease Market - Revenue and Forecast to 2027 (USD Million)
9.4.7.1 UAE: Kidney Disease Market - Revenue and Forecast to 2027 (USD Million)
9.4.7.2 UAE: Kidney Disease Market, by Product Type - Revenue and Forecast to 2027 (USD Million)
9.4.7.2.1 UAE: Kidney Disease Market, by Diagnosis - Revenue and Forecast to 2027 (USD Million)
9.4.7.2.2 UAE: Kidney Disease Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
9.4.7.2.2.1 UAE: Kidney Disease Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
9.4.7.3 UAE: Kidney Disease Market, by End User - Revenue and Forecast to 2027 (USD Million)
9.4.8 South Africa: Kidney Disease Market - Revenue and Forecast to 2027 (USD Million)
9.4.8.1 South Africa: Kidney Disease Market - Revenue and Forecast to 2027 (USD Million)
9.4.8.2 South Africa: Kidney Disease Market, by Product Type - Revenue and Forecast to 2027 (USD Million)
9.4.8.2.1 South Africa: Kidney Disease Market, by Diagnosis - Revenue and Forecast to 2027 (USD Million)
9.4.8.2.2 South Africa: Kidney Disease Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
9.4.8.2.2.1 South Africa: Kidney Disease Market, by Drug Class- Revenue and Forecast to 2027 (USD Million)
9.4.8.3 South Africa: Kidney Disease Market, by End User - Revenue and Forecast to 2027 (USD Million)
9.5 South and Central America: Kidney Disease Market
9.5.1 Overview
9.5.2 South and Central America: Kidney Disease Market - Revenue and Forecast to 2027 (USD Million)
9.5.3 South and Central America: Kidney Disease Market, by Product Type - Revenue and Forecast to 2027 (USD Million)
9.5.3.1 South and Central America: Kidney Disease Market, by Diagnosis - Revenue and Forecast to 2027 (USD Million)
9.5.3.2 South and Central America: Kidney Disease Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
9.5.3.2.1 South and Central America: Kidney Disease Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
9.5.4 South and Central America: Kidney Disease Market, by End User - Revenue and Forecast to 2027 (USD Million)
9.5.5 South and Central America: Kidney Disease Market, by Country, 2019 & 2027 (%)
9.5.6 Brazil: Kidney Disease Market - Revenue and Forecast to 2027 (USD Million)
9.5.6.1 Brazil: Kidney Disease Market - Revenue and Forecast to 2027 (USD Million)
9.5.6.2 Brazil: Kidney Disease Market, by Product Type - Revenue and Forecast to 2027 (USD Million)
9.5.6.2.1 Brazil: Kidney Disease Market, by Diagnosis - Revenue and Forecast to 2027 (USD Million)
9.5.6.2.2 Brazil: Kidney Disease Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
9.5.6.2.2.1 Brazil: Kidney Disease Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
9.5.6.3 Brazil: Kidney Disease Market, by End User - Revenue and Forecast to 2027 (USD Million)
9.5.7 Argentina: Kidney Disease Market - Revenue and Forecast to 2027 (USD Million)
9.5.7.1 Argentina: Kidney Disease Market - Revenue and Forecast to 2027 (USD Million)
9.5.7.2 Argentina: Kidney Disease Market, by Product Type - Revenue and Forecast to 2027 (USD Million)
9.5.7.2.1 Argentina: Kidney Disease Market, by Diagnosis - Revenue and Forecast to 2027 (USD Million)
9.5.7.2.2 Argentina: Kidney Disease Market, by Treatment - Revenue and Forecast to 2027 (USD Million)
9.5.7.2.2.1 Argentina: Kidney Disease Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
9.5.7.3 Argentina: Kidney Disease Market, by End User - Revenue and Forecast to 2027 (USD Million)

10. Impact of COVID-19 Pandemic on Global Kidney Disease Market
10.1 North America: Impact Assessment of COVID-19 Pandemic
10.2 Europe: Impact Assessment of COVID-19 Pandemic
10.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
10.4 Rest of the World: Impact Assessment of COVID-19 Pandemic

11. Kidney Disease Market - Industry Landscape
11.1 Overview
11.2 Growth Strategies Done by the Companies in the Market, (%)
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic Developments
11.4.1 Overview

12. Company Profiles
12.1 Abbott
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 F. HOFFMANN-LA ROCHE LTD.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 AbbVie Inc.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Pfizer Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 TEVA PHARMACEUTICAL INDUSTRIES LTD
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 GlaxoSmithKline plc.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Amgen Inc.
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Sysmex Corporation
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Fresenius SE & Co. KGaA
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Siemens AG
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments

13. Appendix
13.1 Glossary of Terms
Note: Product cover images may vary from those shown
3 of 3
  • Abbott
  • F. Hoffmann-La Roche Ltd.
  • AbbVie's Inc.
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.
  • GlaxoSmithKline plc
  • Amgen Inc.
  • Sysmex Corp.
  • Fresenius Medical Care SE & Co. KGaA
  • Siemens Healthineers AG
Note: Product cover images may vary from those shown
Adroll
adroll